Regeneron Pharmaceuticals
REGN
#231
Rank
โ‚น6.550 T
Marketcap
โ‚น59,606
Share price
-0.90%
Change (1 day)
-14.83%
Change (1 year)

EPS for Regeneron Pharmaceuticals (REGN)

EPS in 2023 (TTM): โ‚น3,085

According to Regeneron Pharmaceuticals's latest financial reports the company's current EPS (TTM) is โ‚น3,173. In 2022 the company made an earnings per share (EPS) of โ‚น3,441 a decrease over its 2021 EPS that were of โ‚น6,493.

EPS history for Regeneron Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น3,085-10.37%
2022โ‚น3,441-47%
2021โ‚น6,493133.36%
2020โ‚น2,78269.13%
2019โ‚น1,645-14.44%
2018โ‚น1,923100.71%
2017โ‚น957.9831.78%
2016โ‚น726.9838.96%
2015โ‚น523.1572.55%
2014โ‚น303.19-17.55%
2013โ‚น367.73-44.98%
2012โ‚น668.38-422.54%
2011-โ‚น207.2292.13%
2010-โ‚น107.8649.41%
2009-โ‚น72.19-15.84%
2008-โ‚น85.78-36.88%
2007-โ‚น135.88-9.6%
2006-โ‚น150.324.12%
2005-โ‚น144.38-323.68%
2004โ‚น64.54-135.51%
2003-โ‚น181.74-24.38%
2002-โ‚น240.3456.35%
2001-โ‚น153.72187.3%
2000-โ‚น53.50-16%
1999-โ‚น63.70177.78%
1998-โ‚น22.93-35.71%
1997-โ‚น35.67-68.42%
1996-โ‚น112.95

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
โ‚น1,202-62.13%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น349.05-111.00%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1,568-50.59%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1,196-62.30%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น317.63-89.99%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚น270.09-91.49%๐Ÿ‡ซ๐Ÿ‡ท France